prikaz prve stranice dokumenta HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder
Rad je dostupan svim korisnicima iz sustava znanosti i visokog obrazovanja RH
Znanstveni rad - Izvorni znanstveni rad
HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder
Molecular Biology Reports, 3 (2011); 2253-2258. https://doi.org/10.1007/s11033-011-0974-0
Buretić-Tomljanović, Alena; Vraneković, Jadranka; Rubeša, Gordana; Tomljanović, Draško; Šendula - Jengić, Vesna; Kapović, Miljenko; Ristić, Smiljana

Institucijski repozitorij: Repozitorij Medicinskog fakulteta u Rijeci

Citirajte ovaj rad

Buretić Tomljanović, A., Vraneković, J., Rubeša, G., Tomljanović, D., Šendula Jengić, V., Kapović, M. i Ristić, S. (2011). HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder. Molecular Biology Reports, 3., 2253-2258. doi: 10.1007/s11033-011-0974-0

Buretić Tomljanović, Alena, et al. "HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder." Molecular Biology Reports, vol. 3, 2011, str. 2253-2258. https://doi.org/10.1007/s11033-011-0974-0

Buretić Tomljanović, Alena, Jadranka Vraneković, Gordana Rubeša, Draško Tomljanović, Vesna Šendula Jengić, Miljenko Kapović i Smiljana Ristić. "HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder." Molecular Biology Reports 3 (2011): 2253-2258. https://doi.org/10.1007/s11033-011-0974-0

Buretić Tomljanović, A., et al. (2011) 'HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder', Molecular Biology Reports, 3, str. 2253-2258. doi: 10.1007/s11033-011-0974-0

Buretić Tomljanović A, Vraneković J, Rubeša G, Tomljanović D, Šendula Jengić V, Kapović M, i sur.. HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder. Molecular Biology Reports [Internet]. 04.06.2011. [pristupljeno 25.12.2024.];3:2253-2258. doi: 10.1007/s11033-011-0974-0

A. Buretić Tomljanović, et al., "HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder", Molecular Biology Reports, vol. 3, str. 2253-2258, Lipanj 2011. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:058200. [Citirano: 25.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:058200
Podaci o radu
Naslov (engleski)HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder
AutorAlena Buretić-Tomljanović
AutorJadranka Vraneković
AutorGordana Rubeša
AutorDraško Tomljanović
AutorVesna Šendula - Jengić
AutorMiljenko Kapović
AutorSmiljana Ristić
MBZ: 142283
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za medicinsku biologiju i genetiku)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Genetika, genomika i proteomika čovjeka
Sažetak (engleski)
The aim of this study was to investigate the possible influence of hemochromatosis gene mutations (HFE-C282Y and H63D) and transferrin gene C2 variant (TF-C2) on susceptibility to schizophrenia and schizoaffective disorder and/or age at first hospital admission. Genotyping was performed in 176 Croatian patients and 171 non-psychiatric Croatian controls using PCR-RFLP analyses. Regarding the H63D mutation, allele and genotype frequencies reached boundary statistical significance. Other allele and genotype distributions were not significantly different between two groups. We also analyzed age at first hospital admission as a continuous variable using the non-parametric Mann–Whitney U-test and Kruskal–Wallis test, and multiple regression analysis. The results of these tests were negative. We concluded that investigated HFE mutations and TF-C2 variant are not high-risk genetic variants for schizophrenia/schizoaffective disorder in our population. Also our data do not support their impact on age at onset of the first psychotic symptoms.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaMolecular Biology Reports
Brojčani podacivol. 3, str. 2253-2258
e-ISSN1573-4978
DOIhttps://doi.org/10.1007/s11033-011-0974-0
URN:NBNurn:nbn:hr:184:058200
Datum objave publikacije2011-06-04
ProjektŠifra: 062-0982522-0369
Naziv (hrvatski): Genetika metabolizma fosfolipida u shizofreniji
Naziv (engleski): Genetics of phospholipid metabolism in schizophrenia
Voditelj: Alena Buretić-Tomljanović
Pravna nadležnost: Hrvatska
Financijer: MZOS
Linija financiranja: ZP
URL dokumentahttps://link.springer.com/article/10.1007/s11033-011-0974-0/fulltext.html#Sec1
Vrsta resursaTekst
Prava pristupaOgraničen pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2017-05-16 10:11:12